Headquartered in Hong Kong, Brinc is a leader in global venture acceleration and operates 15 multidisciplinary accelerator programs across seven countries. Brinc accelerates startups focused on blockchain technology, artificial intelligence, connected hardware, robotics, climate tech, clean energy, food technology, and Internet of Things (IoT) with a view to creating a more sustainable, equitable, and inclusive future. Brinc also supports corporations with distributed innovation strategies, sourcing of new startups and technologies, as well as venture-building Web3-enabled businesses. Global corporations (Manulife, Huawei, Schneider Electric, Puma, Batelco, Merck, Omantel, Linrun Group, Zhihui Park), government organizations (Hong Kong Science Park, NEOM, MBRIF, Guangdong Soft-tech Park), tertiary institutions (HK City University, National University of Singapore), fast-growing companies (Animoca Brands, DayDayCook), and leading venture funds (Artesian, LeverVC, Tamkeen, EDB) have all run programs with Brinc. In 2021, Brinc announced a series of venture funds to invest in high-potential early-stage companies through accelerators and provide LPs with a dedicated innovation platform and access to Series A+ co-investment opportunities.

Brinc

Big Idea Ventures is the world’s most active investor in FoodTech investing in the best food technology and agritech companies globally. The company is focused on alternative protein with its New Protein Fund and commercialization of university intellectual property with its Generation Food Rural Partners fund. BIV is backed by a strong network of strategic partners including AAK, Avril, Bühler, Givaudan, Temasek Holdings, and Tyson Ventures, and is partnering with governments around the world working on food security and new food ecosystems. The firm has offices in New York, Paris and Singapore and has invested in more than 100 companies across 22 countries. For more information, visit bigideaventures.com

Big Idea Ventures

VentureSouq (VSQ) is a MENA-based venture capital fund manager with a global portfolio. VSQ manages thematic funds, with a current focus on FinTech and ClimateTech.

VentureSouq

We invest in breakthrough technologies that positively impact health and climate. We put founders first. Our 12-month US expansion program guides startups on strategy, culture, fundraising, and GTM. Startups get experienced partners and their network, as part of their extended team. We invest in founders working on solutions to fundamentally improve health and climate. We believe that combining purpose and profit leads to impact.

DART Ventures

Masnavi is a globally-focused VC firm investing in early-stage, impact-oriented and talent-driven startups that provide disruptive technologies and solutions within such sectors as Biotechnology, Mental Health, Sustainable Agtech and Foodtech, Spatial Intelligence , Space Exploration and Telecommunication.

Masnavi Capital

Y Combinator is a startup accelerator that invests in a large number of startups twice a year. It created a new model for funding startups. Twice a year, the company invests a small amount of money ($150k) in a large number of startups. The startup accelerator works intensively with the companies for three months, to get them into the best possible shape and refine their pitch to investors. Each cycle culminates in Demo Day when the startups present their companies to a carefully selected, invite-only audience.

Y Combinator

AI practitioners investing in AI, deeptech, robotics, future of work

Outset Capital

Metaplanet Holdings is an early-stage investment firm that invests in diversified sectors. They support novel and evidence-based innovations that could produce an outsized return for the benefit of humankind. The firm specializes in the fields of business development, venture capital, and financial services.

Metaplanet

Established in 2016 and based in Silicon Valley, FoundersX is a deep-domain winner with investment focus on deep tech, enterprise AI and digital infrastructure. We outcompete with our deep-dive research capacity. We are an early investor in multiple tech unicorns with several home runs, and have over 20 high growth companies valued at over $100M. We have highly competitive deal flows and high hit rate. Our firm is featured on the WSJ and Business Insider as a pioneering tech VC.

FoundersX Ventures

Quiet Capital is a technology investment firm.

Quiet Capital

Nucleus Capital is a new venture capital firm supporting purpose-driven founders. We profoundly believe that entrepreneurial innovation is necessary to tackle global threats to human and planetary health. We partner with entrepreneurs at the nucleus of their journey, investing at the Pre/Seed stage and are focussed on Synthetic & Computational Biology, Food- and Climate Technology.

Nucleus Capital

At One Ventures finds, funds, and grows teams to catalyze a world where humanity is a net positive to nature. They back early-stage (Seed, Series A) companies that are using disruptive deep tech to upend the unit economics of established industries while dramatically reducing their planetary footprint. They also look for companies that are pioneering new industries that are actively regenerative to planetary health. Lastly, they look for companies that have significant potential to be healthy, scalable businesses, because the positive impacts they invest in only last as long as the businesses that carry them.

At One Ventures

Prithvi Ventures invests in early-stage startups that fight Climate Change by reducing greenhouse gas emissions

Prithvi Ventures

One of the most active global food-tech VCs. We invest in teams and tech building a better food system.

Tet Ventures

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff.  Since 2004, Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets.  In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai.  In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

Artesian VC

Multinational Tech and Investment Group based in Asunción and San Francisco. We invest in Startups and in other Funds aswell.

Cibersons

Orbillion Bio

Orbillion Bio produces meat from the highest quality heritage animals. Their mission is to realize the promise of cell-cultured meat to make delicious, nutritious food that is sustainable, accessible, and just.

Orbillion Bio is a California-based cell-cultured meat producer developing cultivated beef products. The startup utilizes its high-yielding cell culture platform, Orbiscale, which leverages advanced bioprocessing techniques and machine learning algorithms to create cell lines in bioreactors, isolate cells, and culture media best suited for producing premium meat analogs. The company intends to produce cultivated beef at price parity with conventional beef while reducing CAPEX requirements by 40%.

Making meat sustainable over the long term

Cell-cultured Meat

Earth VC joins US-based cultivated meat startup Orbillion Bio’s funding round

Orbillion Bio is a California-based cell-cultured meat producer developing cultivated beef products. The startup utilizes its high-yielding cell culture platform, Orbiscale, which leverages advanced bioprocessing techniques and machine learning algorithms to create cell lines in bioreactors, isolate cells, and culture media best suited for producing premium meat analogs. The company intends to produce cultivated beef at price parity with conventional beef while reducing CAPEX requirements by 40%.The company is also a member of The Alliance for Meat, Poultry, and Seafood Innovation alongside other alternative meat companies such as Finless Food and BlueNalu.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/13298">September 2022</a>, the company partnered with Dutch specialty meat distributor Luiten Food to launch Orbillion’s cultivated Wagyu across 35 European countries. Further, in <a href="https://sp-edge.com/updates/15145">December 2022</a>, Orbillion Bio partnered with bioprocessing company Solar Biotech to develop and scale its production of cultivated Wagyu beef.Funding and financialsIn <a href="https://sp-edge.com/updates/27582">March 2024</a>, the company secured new funds, bringing the firm's total capital to USD 15 million. The funding round was co-led by The Venture Collective and At One Ventures, with participation from YCombinator, and others. The funds were earmarked for scaling manufacturing capacity, advancing its technical platform and cultivated beef product, and advancing regulatory efforts.

Mosa Meat is a Dutch cell-cultured meat startup founded by Dr. Mark Post of Maastricht University, and was the first-ever company to produce a lab-grown meat burger. The startup produces meat by growing myosatellite cells (muscle stem cells) extracted from an animal in a bioreactor fed with a nutrient-dense medium.The company replaced the fetal bovine serum (FBS) from its growth medium in July 2020, which led to an 88x cost reduction in its medium. As of March 2024, Mosa Meat operated the Center for Advanced Meat Production, Upscaling, and Sustainability (CAMPUS), a facility spanning over 79,000 sq ft that was designed to be expandable as demand grows.In <a href="https://sp-edge.com/updates/21645">September 2023</a>, Mosa Meat became the first cultivated meat company to attain B Corp certification. The company also announced plans to apply for regulatory approval in countries worldwide. In <a href="https://sp-edge.com/updates/21645">September 2023</a>, Mosa Meat became the first cultivated meat company to attain B Corp certification. The company also announced plans to apply for regulatory approval in countries worldwide. In <a href="https://sp-edge.com/updates/31970">July 2024</a>, it conducted the first official tasting of its cultivated beef product, the Mosa Burger, in the Netherlands. This event gathered Dutch cattle farmers, food product developers, and industry representatives to collect expert feedback.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/14175">November 2022</a>, Mosa Meat entered into an agreement with Singapore-based contract development and manufacturing organization (CDMO) Esco Aster to commercialize its cultivated beef in Singapore. Further, in <a href="https://sp-edge.com/updates/16845">March 2023</a>, the company partnered withNutreco to develop a cell feed supply chain that can expedite production and scalability while reducing cost.Funding and financialsIn its latest funding round in <a href="https://sp-edge.com/updates/28536">April 2024</a>, the company raised EUR 40 million (~USD 42.5 million) in an oversubscribed funding round co-led by Lowercarbon Capital and M Ventures, with participation from PHW Group, Invest-NL, LIOF, and LEF. The funds were earmarked for scaling production procedures, reducing production costs, and gearing up for commercialization.

Mosa Meat

SuperMeat is a cellular agriculture startup developing cultured chicken meat. The company uses chicken cells and claims to grow them in a culture medium free from antibiotics and contaminants to develop its products. SuperMeat also operates a test kitchen known as The Chicken. It is claimed to be the world’s first farm-to-fork facility where diners can observe the production of cultivated chicken.In <a href="https://sp-edge.com/updates/21733">September 2023</a>, The Orthodox Union (OU) certified SuperMeat’s cultivated chicken as “kosher.” Further, the OU and SuperMeat will collaborate on establishing guidelines for the industry.In&nbsp;<a href="https://sp-edge.com/updates/35765">November 2024</a>, the company announced it had achieved cost parity for its cultivated chicken and could produce it at at USD 11.79 per pound at scale, matching the price of premium US pasture-raised chicken.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/9319">March 2022</a>, SuperMeat signed an MoU with PHW to supply cultivated meat products including chicken, turkey, and duck to the European market. The company also <a href="https://sp-edge.com/updates/8997">partnered</a> with Ajinomoto to set up a joint venture to accelerate the commercialization of cultivated meat while focusing on developing a cost-competitive cell growth media.In <a href="https://sp-edge.com/updates/11867">July 2022</a>, the company signed an MoU with Switzerland’s largest retail supermarket chain and leading meat manufacturer, Migros to expedite production and distribution of cultured meat at a commercial scale with a focus on European markets.&nbsp;

SuperMeat

Uncommon (formerly HigherSteaks) is a UK-based cell-cultured meat startup that uses cellular agriculture to grow pork from animal cells. The company leverages cellular agriculture and in-house developed RNA technologies to cultivate meat and claims its technology eliminates the need for genetic engineering and growth media.In July 2020, the company unveiled the world's first lab-grown pork belly prototype and the second cell-based bacon (behind Mission Barns cell-based bacon unveiled in early 2020). The pork belly and the bacon were produced from a combination of cell-cultured muscle and plant-based proteins and fat. Uncommon plans to commercialize its cell-cultured meat by 2022-2025, pending regulatory approval.Funding and financialsIn <a href="https://sp-edge.com/updates/19267">June 2023</a>, the company raised USD 30 million in Series A funding co-led by Balderton Capital and Lower Carbon Capital, with participation from Redalpine, East Alpha, and others. The funds were earmarked for the development of its innovative approach, expanding production, increasing the team, and initiating regulatory approvals.

Uncommon

Multus, a spin-off of SOSV’s IndieBio program, is a biotechnology company that specializes in the development of growth media solutions for cellular agriculture applications. Its portfolio includes serum-free FBS alternatives (Proliferum M and Proliferum LSR) and solutions that support cell adhesion (rh-Vitronectin) during the cultivation process.Multus leverages MediOp, a growth media formulation design platform, to develop its solutions. According to the company, this technology allows optimizing solutions using automated data analysis and insights. Multus also uses this platform to provide contract manufacturing services for custom formulation design and food-safe manufacturing compliant with ISO22000 to customers in North America, Europe, and Asia-Pacific.In <a href="https://sp-edge.com/updates/25572">January 2024</a>, the company unveiled what it claims to be the first large-scale production plant making serum-free growth media in the cultivated meat industry.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/24911">December 2023</a>, the company partnered with New Wave Biotech, a bioprocess optimization software company, under a project funded through an Innovate UK Engineering Biology grant. Through this partnership, Multus planned to use New Wave Biotech’s AI software to optimize its process of developing precision-fermented ingredients for cell cultivation.Funding and financialsIn <a href="https://sp-edge.com/updates/15702">January 2023</a>, the company raised GBP 7.9 million (~USD 9.6 million) in a funding round led by Mandi Ventures with participation from SOSV, Big Idea Ventures, and others. The funding from this round was earmarked for the development of its animal-free growth media production facility in London.

Multus

Based in Israel, Believer Meats (Future Meat Technologies prior to November 2022) develops hardware and cell lines for the manufacturing of cell-cultured meat, to commercialize its manufacturing hardware and techniques.Believer Meats uses fibroblast cells that can be triggered with small molecules to develop either fat or muscle cells. Fat and muscle cells are cultured in a unique bioreactor that removes the waste material from the media, allowing the company to recycle parts of the media to reduce feed media input by as much as 50%. The startup replaced FBS with molecules derived from Chinese hamster ovaries (CHO) to reduce production costs and plans to achieve price parity with animal counterparts.In <a href="https://sp-edge.com/updates/12623">August 2022</a>, the company announced it has developed what it claims to be the world’s first cultivated lamb, using cell lines isolated from Awassi sheep.In <a href="https://sp-edge.com/updates/15195">December 2022</a>, the company announced it has begun development of a 200,000 sq foot production facility in Wilson, North Carolina with an annual capacity of ~22 million lbs, which is claimed to be the largest cultivation facility in the world. Believer Meats plans to produce cultured chicken, pork, beef, and lamb for US, European, and Asian markets.Key customers and partnershipsIn March 2022, the company <a href="https://sp-edge.com/updates/9320">partnered</a> with Charoen Pokphand Foods to develop cultivated meat products for Asia.In <a href="https://sp-edge.com/updates/17710">April 2023</a>, Believer Meats signed an MoU with Archer Daniels Midland (ADM) to collaborate on the development and commercialization of cultivated meat products. Further, ADM will offer its ingredient pantry and nutrition knowledge to enhance Believer's cell-cultivated meat process.In <a href="https://sp-edge.com/updates/30520">June 2024,</a> Believer Meats partnered with Abu Dhabi’s AgriFood Growth &amp; Water Abundance (AGWA), to advance cultivated meat production in the MENA region.Funding and financialsIn its <a href="https://sp-edge.com/updates/9252">latest funding round</a> in December 2021, the company raised USD 347 million in Series B funding, recording the largest investment in cell-cultured meat at the time. The round was co-led by ADM Ventures, while funds were to be used to accelerate its production plans in the US.

Believer Meats

Producers of cell-cultured seafood using cells extracted from fish. Startups have succeeded in developing prototypes of yellowtail and salmon

Producers of cell-cultured pork using cells extracted from animals. Startups have succeeded in developing prototypes of bacon and pork belly using cultured muscle and plant-based proteins and fat

Producers of cell-cultured beef using cells extracted from animals. Some producers in the industry are developing premium beef ranges such as Wagyu. Startups have only succeeded in developing prototypes in the minced form, with a few creating prototypes of (pieces of) steak using 3D bioprinters

Producers of cell-cultured chicken and duck using cells extracted from animals. Some producers in the industry are developing rare delicacies such as foie gras. Startups have only succeeded in developing products in the nugget form

Producers of growth media for cell-cultured meat production and ingredients for meat and meat analog (cell-cultured, plant-based) producers, which can include cell culture meat paste, culture fat, etc. Producers of growth media mainly focus on developing alternative growth media to FBS using plant-based or other sources

Developers of bioreactors and other technologies used in cell-cultured meat production. Industrial scaling and efficiency gains are key areas of interest for startups in the industry

Provide sustainable solutions for animal slaughter through the use of biotechnology

ANALYST_QUICK_TAKE

<div>
 California-based cultivated meat producer, Orbillion Bio, has raised an additional USD 15 million in a funding round. Notable contributors include The Venture Collective, At One Ventures, YCombinator, Metaplanet, and several university endowments.
 The newly acquired capital will be used to scale up manufacturing, further develop its technical platform and cultivated beef product, and navigate regulatory protocols.
</div> Analyst QuickTake: 
 Scaling up to commercial capacity is a major challenge for cultivated meat companies due to high-cost requirements and scarcity of sufficient bioreactor capacity. Recently, Orbillion Bio completed a 200-litre production run of its cultivated meat, marking the largest run conducted by a pre-Series A company in the sector. Further, in <a href="https: 
//sp-edge.com/updates/15145"> December 2022 </a> , the company partnered with Solar Biotech to scale up to 20,000-litre bioreactors capable of producing over 4 million lbs of cultivated beef annually.&nbsp;

Orbillion Bio

EDGE Insights

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless